Immune Mechanisms at the Maternal-Fetal Interface (R01 Clinical Trial Not Allowed)

Funding Opportunity RFA-AI-23-027 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to solicit applications to: improve the understanding of the roles and interactions of immune cells at the maternal-fetal interface that support pregnancy and enable optimal placental development and function; and elucidate the mechanisms by which infection, vaccination, or environmental perturbations during gestation modulate immune responses in the pregnant individual and alter systemic or tissue-specific immunity in the offspring.